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Abstract The K3AL1 integrin is a laminin receptor with a broad
specificity for different laminin isoforms. Furthermore, it
regulates the function of other integrins, like K2L1, K5L1 and
K6AL1. In a yeast two hybrid screen of a human placenta cDNA
library, we identified cDNAs coding for four different proteins
that strongly interact with the conserved region of the
cytoplasmic domain of the K3A integrin subunit. In addition to
the cDNA for nucleotide exchange factor Mss4 and the putative
tumour suppressor protein BIN1, two novel cDNAs were
identified. Association analysis with different integrin subunits
revealed them as cDNAs that encode binding proteins which
react with a broad spectrum of K subunits. The conserved
membrane proximal region of the K3A chain was identified as the
binding site for all four proteins. They, therefore, may be
involved in the regulation of general functions of integrins.
z 1999 Federation of European Biochemical Societies.
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1. Introduction
Integrins are transmembrane K/L heterodimeric receptors
that provide a link between extracellular matrix proteins
and the cytoskeleton [1^3]. The majority of the integrin mol-
ecules have large extracellular domains and small intracellular
parts. The extracellular domains determine the speci¢city of
ligand binding and provide the outside-in signalling, while the
intracellular C-terminal sequences transfer the signal into the
interior of the cell and further modulate the a⁄nity of the
receptor for its extracellular ligand in response to environ-
mental and developmental factors (inside-out signalling) [1^
4]. Both K and L cytoplasmic domains possess a stretch of
highly conserved amino acids proximal to the cell membrane.
Deletion of these amino acid sequences in either the K or the L
chain results in a state of high a⁄nity of the KIIbL3 platelet
receptor, while preservation of only the conserved region
without the rest of the protein chain is enough to prevent
this activation [5^8]. In other cells, in which integrins do not
require activation for ligand binding, like KIIbL3, deletion of
the K cytoplasmic domain directly after the conserved
KXGFFKR region, leads to their recruitment into focal ad-
hesion complexes independent of ligand binding and to a di-
minished cell adhesion [9^11]. The presence of 3^4 amino
acids after the conserved region restores the normal function.
Interestingly, addition of just two alanine residues after the
conserved motif also partially restores the function of the
truncated receptor [10]. These data, together with results of
numerous experiments with point and deletion mutants of the
conserved K cytoplasmic domains, highlight the importance of
this region in integrin-mediated signalling. The mechanism by
which this region modulates integrin activity is, however, still
unknown.
The ligand binding of integrins is not very speci¢c. For
example, K3L1 binds all laminin isoforms except laminin 1,
having, however, the highest a⁄nity for laminin 5 [12,13].
Furthermore, several integrins are able to bind the same li-
gands and often the same domains on the ligands. For exam-
ple, K6L1, K6L4 and K7L1 all bind to the proteolytic fragment
E8 of laminin 1 [12^14]. Nevertheless, integrins also seem to
perform speci¢c cellular functions as demonstrated by the
developmentally and tissue restricted expression of certain in-
tegrins as well as by the results of numerous in vitro di¡er-
entiation studies. For instance, myoblasts form myotubes on
laminin, but not on ¢bronectin, for which the K5L1 integrin is
the preferential receptor, although these cells express integrins
for both ligands [15,16]. Similarly, neuronal di¡erentiation of
rat pheochromocytoma cells is facilitated by laminin rather
than by ¢bronectin [17]. By contrast, di¡erentiation of eryth-
roblasts is supported by the activation of the ¢bronectin-spe-
ci¢c K5L1 integrin [16].
Although both K and L cytoplasmic tails are involved in
ligand binding and modulation of integrin function, they play
clearly di¡erent roles. Overexpression of only the L cytoplas-
mic domain as a part of the transmembrane chimeric mole-
cule, but not that of K, has a dominant negative e¡ect, dis-
rupting the integrin function and cell adhesion [8,18,19]. The
exchange of cytoplasmic domains between K or L subunits
does not abrogate the ligand binding, but the regulation of
the a⁄nity state of the integrins depends on the type of cells
in which these chimeric molecules are expressed [19,20]. Fur-
ther, depending on whether K3- or K6-, associated with L1, is
activated, the morphology of focal adhesions is di¡erent, with
the K3 chain regulating the function of the K6 subunit [21]. It
has been shown also that K3L1 regulates the formation of
focal adhesions of K2L1 and K5L1 integrins as well as cell
migration mediated by these receptors [22].
As integrin K and L cytoplasmic domains have no enzy-
matic activities, they probably provide signals by recruiting
and binding other proteins or messenger molecules. Interac-
tions of integrins with other proteins are probably involved
also in processes such as the transport of proteins to the Golgi
complex, their redistribution on the cell surface and others. In
an attempt to identify such intracellular proteins, we screened
a human placenta cDNA library using the yeast two hybrid
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system with the cytoplasmic domain of the K3A chain as a
bait.
2. Materials and methods
2.1. Plasmid construction
Total RNA from the human HBL100 cell line was isolated using
the RNeasy kit (Qiagen, Hilden, Germany). cDNA fragments repre-
senting the cytoplasmic domains of alpha 2, alpha 3A, alpha 5, alpha
6A and beta 1A integrins were ampli¢ed by RT-PCR using the iso-
lated RNA as template. The following primers were used: for alpha 2,
5P-CCGAATTCAAGCTCGGCTTCTTCAAAAG-3P (upstream) and
5P-ATGGATCCTGGCAACTTTGGATGAGCAG-3P (downstream):
for alpha 3A, 5P-ACGGATCCGAATTCAAGTGCGGCTTCTT-
CAAGCG-3P (upstream) and 5P-CCTGTGGACTGTCAGAGGC-3P
(downstream): for alpha 5, 5P-CCGAATTCAAGCTTGGATTCTT-
CAAACGC-3P (upstream) and 5P-CAGGCAGAACCCAAATTCTG-
CAG-3P (downstream): for alpha 6A, 5P-ACGGATCCGAATTC-
AAGTGTGGTTTCTTCAAGAAG-3P (upstream) and 5P-GTTCCA-
CTTTGTGATCCACTG-3P (downstream): for beta 1A, 5P-CCGGA-
ATTCAAGCTTTTAATGATAATTCATGAC-3P (upstream) and 5P-
TCCGCTCGAGGGATCCAACTAGCTAGCAGGACATTTAC-3P
(downstream). All upstream primers were designed to include an
EcoRI restriction site. The downstream primers correspond to the
3P-untranslated regions of integrin sequences and include either a nat-
ural or an arti¢cial BamHI restriction site. The resulting PCR prod-
ucts were cloned into EcoRI/BamHI restriction sites in the pAS2-1
vector (Clontech, Palo Alto, CA, USA) containing the GAL4 DNA
binding domain.
cDNA fragments representing the complete cytoplasmic domains of
the human alpha 3A* and -B*, the human alpha 6A* and -B*, and
the murine alpha 7A* and -B* integrin receptors were ampli¢ed by
PCR using as template full length cDNA constructs for alpha 3A*
and -B* [23] and alpha 6A* and -B* [24] or a murine muscle lambda
gt11 library (Clontech, Palo Alto, CA, USA) for alpha 7A* and -B*.
The following primers were used: for alpha 3A* 5P-CTGTG-
GAAGCTTGGCTTCTTC-3P (upstream), for alpha 3B* 5P-CTG-
TGGAAGCTTGACTTCTTTAAG-3P (upstream) and 5P-ACTTCTA-
GATGCACTCGGCGTTGT-3P (downstream) for both alpha 3A*
and 3B*. For alpha 6A* and 6B* 5P-ATACTATGGAAGC-
TTGGTTTCTTC-3P (upstream), 5P-CCGGAATTCCGCTATGAG-
TAG-3P (downstream) for alpha 6A*, and 5P-GAAGAAACCAA-
GCTTCCATAGTAT-3P (downstream) for alpha 6B*. For alpha
7A* 5P-CCCAAGCTTGGCTTCTTCCGTCGGAACAGTC-3P (up-
stream), for alpha 7B* 5P-CCCAAGCTTGGATTCTTCAAGCGGG-
CGAAGC-3P (upstream) and 5P-TGGAAAAGGGCGAAAGGAAC-
3P (downstream) for both alpha 7A* and 7B*.
All upstream primers for constructs marked with an asterisk were
designed to include a HindIII site at the start of the DNA sequence
encoding the cytoplasmic domain, resulting in the change of a Cys
residue immediately in front of the conserved GFFKR domain to a
Leu residue. Downstream primers corresponding to the 3P-untrans-
lated regions of the integrin sequences included XbaI (for alpha 3),
EcoRI (for alpha 6) or no (for alpha 7) sites. The resulting PCR
products were subcloned into pBluescript II KS(+) (Stratagene, La
Jolla, CA, USA), cut with the appropriate restriction enzymes and
characterised by DNA sequencing. DNA fragments containing the
complete integrin cytoplasmic domains were released from the pBlue-
script subclones by restriction digestion with ClaI and SmaI (5P and 3P
of the integrin sequence, respectively), treated with Klenow DNA
polymerase in the presence of dNTPs and subcloned into pAS2-1
cut with SmaI. This ensured cloning of the integrin sequences in frame
with the GAL4 DNA binding domain protein. The alpha 1* integrin
chain was cloned into the pAS2-1 vector after annealing of primers
comprising the entire cytoplasmic domain of K1 and NdeI/EcoRI
compatible overhangs. The primers were: 5P-TAT GAA GAT TGG
ATT CTT CAA AAG ACC ACT GAA AAA GAA AAT GGA
GAA ATG-3P (upstream) and 5P-AAT TCA TTT CTC CAT TTT
CTT TTT CAG TGG TCT TTT GAA GAA TCC AAT CTT CA-
3P (downstream).
The alpha 3A deletion mutants were generated by PCR using the
pAS2-1/K3A plasmid DNA as a template. For alpha 3A (1015^1021)
and alpha 3A (1015^1024) the primers were chosen in such a way that
after their annealing, EcoRI and BamHI compatible overhangs were
created. The primers were: for alpha 3A (1015^1021), 5P-AATT-
CAAGTGCGGCTTCTTCAAGCGATGAG-3P (upstream) and 5P-
GATCCTCATCGCTTGAAGAAGCCGCACTTG-3P (downstream)
and for alpha 3A (1015^1024), 5P-AATTCAAGTGCGGCTTCTT-
CAAGCGAGCCCGCACTTGAG-3P (upstream) and 5P-GATCCT-
CAAGTGCGGGCTCGCTTGAAGAAGCCGCACTTG-3P (down-
stream): for alpha 3A (1022^1051) the upstream primer was 5P-
CCGAATTCGCCCGCACTCGCGCCCTG-3P and the downstream
primer was the same as for wild-type alpha 3A. The PCR products
were subcloned into EcoRI/BamHI in the pAS2-1 vector. Point muta-
tions were also generated by PCR, using the same primers as for
obtaining the wild-type alpha 3A, except for nucleotide exchanges
in the upstream primers for corresponding amino acid substitutions.
All pAS2-1 subclones were analysed by DNA sequencing to con¢rm
the correct in frame fusion of GAL4 and integrin sequences.
A human placenta cDNA library, cloned into the pACT2 vector
fused with the GAL4 activation domain as well as the pAS2-1/
LAM5P-1 construct, which was used as a negative control in interac-
tion tests with proteins identi¢ed in a two hybrid screen, were pur-
chased from Clontech (Palo Alto, CA, USA).
2.2. Yeast two hybrid library screening
Yeast cultures were grown under standard conditions in liquid or
on solid media using YPD or minimal SD media. The yeast strain
Y190 (Clontech, Palo Alto, CA, USA) was transformed sequentially
with the pAS2-1 plasmid containing alpha 3A (aa 1015^1051) as bait
and then with a pACT2 plasmid containing the cDNA library. Trans-
formants were grown on SD medium lacking the amino acids leucine,
tryptophan and histidine in the presence of 25 mM 3-amino-1,2,4-
triazole. On day ¢ve, the grown colonies were tested for the activity
of the LacZ reporter gene in a L-Gal ¢lter assay.
2.3. Mating and transformation assay
To remove the bait cDNA, clones scored as positive during the
screening, were further recultured on SD medium without tryptophan
in the presence of 10 Wg/ml cycloheximide. The cycloheximide resist-
ant Y190 yeast clones were veri¢ed in a mating assay with yeast strain
Y187 expressing the pAS2-1 plasmid with either alpha 3A, the unre-
lated protein lamin C, or the non-fused GAL4 DNA binding domain
as baits. Clones were scored as positive when the HIS and LacZ
phenotype of yeast cells was dependent on the coexpression of only
alpha 3A as bait. The positivity of these clones was further retested in
a cotransformation assay with puri¢ed plasmid cDNA using the same
controls as in mating assays.
3. Results and discussion
3.1. Identi¢cation of proteins binding to the conserved region of
the K3A cytoplasmic domain
Of a total of 1.4U107 clones screened, 159 appeared to
interact with K3A, but only 84 of them had a HIS and
LacZ phenotype after K3A was expressed, but not after co-
expression of the unrelated lamin C protein or the non-fused
GAL4 DNA binding domain. cDNA sequencing of the 84
K3A interacting clones revealed ¢ve genes. Two or three
clones of each identi¢ed gene were used to map the binding
site on the K3A integrin subunit. For this purpose, three dif-
ferent deletion mutants of K3A were created (Fig. 1). The
peptides encoded by two cDNA clones interacted with the
highly conserved KXGFFKR region just proximal to the
membrane and for those encoded by the other two, three
additional residues beyond this conserved motif were required
for interaction (Fig. 1). The peptide encoded by the ¢fth clone
did not interact with the conserved motif and will be described
elsewhere. Here we report only clones whose products bind to
the conserved region of K3A.
BLAST search in the NCBI data bank [25] revealed that
two of these four clones encode known polypeptides, Mss4
(accession # S78873) and BIN1 (accession # AF068915),
whereas the two others encode novel proteins. The most fre-
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quent clone (48) always contained a cDNA with the entire
open reading frame of the guanine nucleotide exchange factor
Mss4 [26]. The encoded 14 kDa Zn2 binding protein is found
in all mammalian tissues, with the highest level of expression
in brain, lung, liver, kidney and pancreas [27]. It binds to
Rab3a GTPase, localised in the membrane of cytoplasmic
vesicles, promoting GDP-GTP exchange, and it presumably
plays a role in processes regulating the vesicular transport,
facilitating, for example, the release of neurotransmitter
[27,28]. The second isolated clone of known sequence was
found twice as a 1.7 kb long insert. It represented the 3P
half of the cDNA for BIN1 including the 3P-untranslated
region. BIN1 has recently been described as a protein strongly
expressed in skeletal muscle and brain [29,30]. This protein
has a SH3 domain and a Myc interacting site and is a putative
tumour suppressor. Di¡erent splice variants of this protein
were identi¢ed, and the variant encoded by cDNA containing
the exon 10 has been reported to be upregulated in di¡eren-
tiated muscle cells [30,31]. Overexpression of BIN1 promotes
myotube formation and upregulation of the myosin heavy
chain [31].
The sequences of the other selected clones, 63 and 80, were
novel. Clone 63 (accession # AJ131721) was identi¢ed as a 2.0
kb cDNA insert with an open reading frame which does not
contain an obvious starting Kozak motif. Searching in data
base banks revealed both 5P- and 3P extending EST clones
which suggests, that clone 63 does not contain the whole
coding sequence. The second clone encoding a polypeptide
with a novel sequence, the clone 80 (accession # AJ131720),
occurred eight times. All eight clones had identical 3P regions
and contained a stop codon, while at the 5P end they were
di¡erently extended, the largest of them containing about
2.5 kb of open reading frame. Searching in the data banks
did not reveal any EST clones that extended clone 80 in both
5P and 3P direction. As the ¢rst methionine with a nearly
optimal Kozak motif is localised about 600 bp downstream
from the 5P end of the available sequence, the 2.5 kb long
clone 80 probably does not represent the full length cDNA
sequence. Comparison of clones 63 and 80 with available
cDNA and protein data banks did not reveal any similarity
or homology to any of these sequences or motifs, except for
the presence of numerous putative phosphorylation sites for
PKA, PKC and CK2 kinases as well as putative myristoyla-
tion sites.
3.2. Mapping of amino acids essential for protein binding in the
conserved region of K3A
The transmembrane regions of K and L integrins are
thought to assume an K-helical structure that might be ex-
tended into the cytoplasmic domain [32,33]. The last residue
of the transmembrane region is obligatorily an aromatic ami-
no acid, either tryptophan or tyrosine, and the ¢rst cytoplas-
mic residue that follows is always a lysine. During the con-
struction of GAL4/K3A clones, two chimeric constructs were
generated. In the ¢rst construct the seven KCGFFKR amino
acids of the conserved region were kept unchanged and an
aromatic phenylalanine was inserted before the ¢rst lysine.
In creating the second GAL4/K3A* fusion construct, another
cloning strategy was used which resulted in the exchange of
the aromatic amino acid for negatively charged aspartic acid
and of the second cysteine (which is not conserved among K
chains) for leucine. Surprisingly, the second K3A* chimeric
protein did not bind to Mss4 or clone 63 in a direct two
hybrid interaction assay (Fig. 2). To test whether the above
two amino acids are essential for binding to the conserved
region, K3A mutants were constructed, in which the cysteine
at position +2 was exchanged for leucine and the phenylala-
nine at the position 31 for either aspartate or tryptophan
(Fig. 2). As expected, exchange of the non-conserved cysteine
at the position +2 had no in£uence on the binding capacity of
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Table 1
Results of the L-galactosidase ¢lter assay with cytoplasmic domains of integrin subunits
Proteins K1* K2 K3A K3A* K3B K3B* K5 K6A K6A* K6B* K7A* K7B* L1A
Mss4 3 +++ +++ 3 + 3 +++ +++ 3 3 3 3 3
Clone 63 3 +++ +++ 3 +++ 3 +++ +++ NT 3 3 3 3
BIN1 +++ 3 +++ + ++ ++ 3 3 NT ++ 3 3 3
Clone 80 3 +++ +++ +++ 3 3 3 ++ NT +++ +++ 3 3
Integrin K chains marked with (*) possess either a methionine (for K1) or an aspartate before the ¢rst lysine of the conserved region which resulted
from a di¡erent cloning strategy into the pAS2-1 vector. NT = not tested.
Fig. 1. The interaction of K3A deletion mutants with proteins identi¢ed in a two hybrid screen as potential K3A binding partners. The interac-
tion was determined by growth on His3 medium (growth results from activation of the ¢rst reporter gene) and evaluated further in a L-Gal ¢l-
ter assay for expression of the second reporter gene, LacZ. Yeast Y190 cells were transformed with pAS2-1 plasmid DNA expressing the integ-
rin cytoplasmic domains along with the pACT2 vector bearing the identi¢ed proteins. The interaction was scored as negative (3) when no blue
colonies were visible after 8 h: the interaction was scored as weak (+), intermediate (++) or strong (+++) when blue colonies became visible
after 8 h, 4 h or 1 h, respectively. Numbers in parentheses refer to amino acid positions.
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any of the four analysed proteins. However, Mss4 and clone
63, but not BIN1 and clone 80, failed to interact with K3A
when the phenylalanine at position 31 was exchanged for the
negatively charged aspartate. In contrast, all clones strongly
bound to K3A when a tryptophan residue, that naturally oc-
curs in K3A, was present instead of phenylalanine at position
1014 (Fig. 2). Thus, the aromatic amino acid before the ¢rst
lysine of the conserved region which may be located in the
membrane, either functionally belongs to the cytoplasmic do-
main, or substitution of this hydrophobic residue by a nega-
tively charged one disrupts the proposed K-helical structure of
the chain.
It has been shown that substitution of the ¢rst lysine or the
arginine of the KXGFFKR region for negatively charged as-
partic acid results in the loss of ligand-dependent focal contact
localisation, whereas the exchange of these positively charged
amino acids to a more hydrophobic alanine did not change
the properties of the receptor [6,34^36]. Their replacement by
aspartates alters the charge of the K chain, which may a¡ect
subunit association, transmembrane integrity of the K/L het-
erodimer and the function of the cytoplasmic domains [6,32^
34]. The two hydrophobic phenylalanines in the KXGFFKR
sequence have been shown to be also critical for the modu-
lation of the a⁄nity of integrins, as their replacement by ala-
nines induced constitutive activation of the KIIbL3 integrin
[6]. Either exchange of phenylalanines for alanines, or their
deletion in the K6A integrin sequence prevented the expression
of this subunit at the surface of K562 cells, due to failure of
association with the L1 integrin subunit. The mutated K6A
chains were synthesised, but not transported to the Golgi
apparatus [11]. To test whether positively charged arginine
and two hydrophobic phenylalanines are essential for binding
to K3A, these were exchanged with a negatively charged as-
partate and with polar tyrosines, respectively. K3A-dependent
binding of clone 63 was not a¡ected by these point mutations.
However, Mss4 did not interact with K3A when either the
arginine or the two phenylalanines were replaced by other
amino acids. For BIN1 and clone 80 these modi¢cations
had di¡erent e¡ects (Fig. 2). Interestingly, the replacement
of only the ¢rst phenylalanine by tyrosine had no in£uence
on the binding of any of the four proteins, while the exchange
of this residue with alanine produced a more pronounced
e¡ect, preventing binding of BIN1 and clone 80 (data not
shown). We conclude from these data that while all four an-
alysed proteins need the conserved region for binding to the
K3A integrin subunit, their binding patterns are di¡erent, as
the speci¢c amino acids required by these proteins di¡er.
3.3. Binding speci¢city for the conserved region of K chains
To assess whether the identi¢ed proteins bind speci¢cally to
K3A, a direct two hybrid interaction assay was performed
with cytoplasmic domains of several other integrin subunits.
The K subunits of typical collagen binding receptors (K1 and
K2), of a ¢bronectin binding receptor (K5) as well as K chains
from additional laminin binding integrins (K3B, K6A, K6B,
K7A and K7B) were used. As a non-K chain, the L1A subunit
of these integrins was used (Table 1). None of the four iso-
lated clones bound to the L1A subunit, which shows that they
are speci¢c for the K subunit. However, none of the proteins
bound only K3A. Mss4 and the clone 63 bound all K chains
that had an aromatic amino acid before the ¢rst lysine of the
conserved region, while the binding pattern of BIN1 and clone
80 appeared to be more restricted (Table 1). This provides
further support for the conclusion made above that the aro-
matic amino acid residue before the conserved region of in-
tegrin K chains is essential for their interaction with Mss4 and
clone 63. Additionally, when the aspartate before the ¢rst
lysine of the K3B cytoplasmic domain was replaced by phenyl-
alanine, K3B showed a strong interaction with clone 63 and a
moderate interaction with Mss4. As among the tested K sub-
units, K5 is the only non-laminin binding receptor, BIN1 and
clone 80 proteins appeared to be laminin receptor-restricted
interaction proteins. The restricted binding pattern of BIN1
and clone 80 may re£ect the redundancy of laminin binding
integrin receptors [12,36]. Although the binding sites for BIN1
and clone 80 were also mapped to the membrane proximal
conserved region (3/+ the following three amino acids), the
restricted manner in which they bind to di¡erent K chains
indicates an in£uence of the unique C-terminal amino acids
in these processes.
The membrane proximal conserved motif of integrin K
chains represents the region that has been shown to be critical
for the receptor function of integrins. If the GFFKR sequence
is partially deleted or replaced by alanines the a⁄nity of the
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Fig. 2. The identi¢cation of amino acid residues in the conserved region of integrin K3A chain that are essential for the binding of the four
identi¢ed interactive proteins. Numbers in parentheses refer to amino acid positions. The shaded letters in the K3A sequence represent amino
acids that have been mutated. For simplicity only amino acids of the conserved region are presented. NT=not tested.
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KIIbL3 integrin shifts from low to high [37]. Despite sequence
di¡erences, several cytoplasmic domains of K chains can be
interchanged without loosing their cell adhesion capacity (re-
viewed in [35]). However, deletion of unique sequences di-
rectly after the conserved KXGFFKR motif abolishes the
constitutive ligand binding activity and the ligand-dependent
recruitment into focal contacts of K1L1 [31], K2L1 and K4L1
[9,10] or K6L1 [11] integrins. Preservation of only 3^4 amino
residues beyond the conserved region was su⁄cient to restore
both properties. Surprisingly, addition of only two alanines to
the C-terminal part of KXGFFKR also partially prevented
the functional defects of receptors with truncated unique se-
quences [10]. The fact that the binding region on K3A for four
proteins found in the two hybrid screen was mapped to the
conserved region or to this region as well as the next three
amino acids, raises the possibility that the proteins identi¢ed
as K3A binding partners regulate processes common to several
or even all integrins.
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